Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Association of tirzepatide with reverse cardiac remodeling and improved diastolic function in obesity-related HFpEF: A prospective real-world cohort study
International journal of cardiology, 2026;:134773
Weight regain following discontinuation of glucagon-like peptide-1 receptor agonists in adults who are overweight or obese: a systematic review and meta-analysis
PeerJ, 2026;14:e21713
Off-label semaglutide: A call for monitoring protocols in non-obese populations
JPMA. The Journal of the Pakistan Medical Association;76(8):1402
Screening for Metabolic Dysfunction-Associated Steatohepatitis in Adults with Type 2 Diabetes in the U.S. and 5 European Countries: A Cost-Utility Analysis
JHEP reports : innovation in hepatology, 2026;:102018
Association of Tirzepatide versus Semaglutide with Risk of Asthma Exacerbation in Patients with Asthma and Type 2 Diabetes: A US Multicenter Retrospective Cohort Study
Journal of asthma and allergy, 2026;19:637738
Case report: Tirzepatide-responsive refractory diabetes mellitus in an adult female with prader-willi syndrome
Medicine;105(36):e50605
Improvement of post-COVID-19 vaccination dysautonomia with GLP-1 receptor agonist
Immunopharmacology and immunotoxicology, 2026;:1-6
HIF-1 exerts a double-edged sword regulatory role in hippocampal neuronal PANoptosis of Alzheimer’s disease through HK2/VDAC1/NLRP3 axis and RIPK3 signal
Pharmacological research, 2026;:108440
A Systematic Review and Meta-Analysis of Malnutrition and Metabolic Failure in High-Potency Incretin Therapy
Obesity science & practice, 2026;12(5):e70188
Key Experimental Therapeutics and Knowledge Gaps in Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Drug design, development and therapy, 2026;20:543657
Metformin-Associated Lactic Acidosis and Relative Euglycemic Ketoacidosis Precipitated by a Glucagon-Like Peptide-1 Receptor Agonist: A Case Report and Literature Review
Kidney360, 2026
Oral Incretin-Based Therapies for Weight Management
Current atherosclerosis reports, 2026;28(1)
Are We Asking About Tirzepatide? Emerging Oral Health Implications for Oral Medicine Practice
Oral diseases, 2026
Adjunctive Treatments for Patients with Type 1 Diabetes Using Automated Insulin Delivery Systems. A Narrative Review
Diabetes technology & therapeutics, 2026;:15209156261486127
Recent Advances in Glucagon-Like Peptide-1 Receptor and Melanocortin-4 Receptor Agonists for the Treatment of Obesity and Type 2 Diabetes
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2026
Emerging role of GLP-1 mono, dual, and triple agonists in the management of MASH-related fibrosis
Cell reports. Medicine, 2026;:103023
The Evolution of Medications for Obesity Management
JGH open : an open access journal of gastroenterology and hepatology, 2026;10(9):e70466
From insulin resistance to incretin receptor agonism in the prevention of type 2 diabetes mellitus in obese individuals
Current medical research and opinion, 2026;:1-15
Glucagon-Like Peptide-1 Receptor Agonists for Obstructive Sleep Apnea: A Review
JAMA otolaryngology-- head & neck surgery, 2026
Obesity, fasting, and chronic migraine: Can semaglutide disrupt the vicious cycle?
Headache, 2026